Pinz Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $270K | Buy |
+3,400
| New | +$270K | 0.49% | 62 |
|
|
2022
Q1 | – | Sell |
-7,200
| Closed | -$806K | – | 224 |
|
|
2021
Q4 | $806K | Buy |
7,200
+3,800
| +112% | +$425K | 0.31% | 87 |
|
|
2021
Q3 | $427K | Buy |
+3,400
| New | +$427K | 0.19% | 72 |
|
|
2021
Q2 | – | Sell |
-3,000
| Closed | -$407K | – | 573 |
|
|
2021
Q1 | $407K | Buy |
+3,000
| New | +$407K | 0.11% | 97 |
|